Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2013 Q1- Text added to 2013 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
advancing, Affordable, alleged, asserting, banc, BLA, cell, Central, Circuit, committed, competitor, complicated, concurrent, declaratory, deep, dramatically, duty, elevated, en, enrollment, ERISA, experience, fiduciary, giant, insurance, invalid, invalidity, lab, Larson, LDL, medicine, moderate, organization, ovarian, paclitaxel, peginesatide, people, PFS, population, pressure, promise, recurrent, rehearing, remanded, removed, resume, Roche, Sandoz, science, slightly, stipulation, suspended, temporarily, trebananib, tumor, unenforceability
Valuein 2013 Q1 filing- Value in 2013 Q2 filing
Original filings
Filing view